Herpes Simplex and Varicella Zoster

  • Sharif Currimbhoy
  • Arturo Ricardo Dominguez


Herpes simplex virus types one and two (HSV-1 and HSV-2) affect millions of Americans and causes a lifelong, recurrent rash characterized by vesicles and ulcers that can last for 10–14 days. HSV-1 is often acquired in childhood by nonsexual transmission and most commonly affects the oral mucosa, whereas HSV-2 is sexually transmitted and causes genital lesions. African American patients are disproportionately affected by genital herpes compared to Caucasians. Herpes zoster is caused by reactivation of the varicella zoster virus and presents as an intensely painful, vesicular rash that is distributed along a dermatome. Treatment for both conditions includes oral antivirals for an episodic outbreak or suppressive therapy for recurrent herpes simplex.


Herpes Simplex Virus Herpes Zoster Varicella Zoster Virus Genital Herpes Postherpetic Neuralgia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73.PubMedCrossRefGoogle Scholar
  2. 2.
    Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med. 2004;350(19):1970–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Beauman JG. Genital herpes: a review. Am Fam Physician. 2005;72(8):1527–34.PubMedGoogle Scholar
  4. 4.
    Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis. 2006;12(3):254–70.PubMedCrossRefGoogle Scholar
  5. 5.
    Pouget ER, Kershaw TS, Blankenship KM, Ickovics JR, Niccolai LM. Racial/ethnic disparities in undiagnosed infection with herpes simplex virus type 2. Sex Transm Dis. 2010;37(9):538–43.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013;369(3):255–63.PubMedCrossRefGoogle Scholar
  7. 7.
    Sengupta S. Cutaneous herpes zoster. Curr Infect Dis Rep. 2013;15(5):432–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20–31.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Sen P, Barton SE. Genital herpes and its management. BMJ. 2007;334(7602):1048–52.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Habif TP, Campbell JL, Shane Chapman M, et al. Skin disease, diagnosis and treatment. Edinburgh: Saunders; 2011.Google Scholar
  11. 11.
    Leinweber B, Kerl H, Cerroni L. Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects. Am J Surg Pathol. 2006;30(1):50–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of DermatologyUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations